Cannabis can help combat antibiotic resistance, according to research

47 0

Studies provide insight into how marijuana is helping protect bodies

The growing resistance to antibiotics is a serious public health problem worldwide. For years, therefore, the scientific community has been focusing its efforts on the search for new strategies and compounds to combat resistant bacteria. Now, different studies delve into the antibacterial potential of certain cannabis compounds. Such effects make the plant essential in the fight against antibiotic resistance.

The good news is that although medical efforts to develop more potent antimicrobials are a bit slow, it is now possible to return to the ancestral cannabis plant, which may have properties in this regard. There are many gaps in this regard still, but in the studies available so far, this plant has once again shown that it may be humanity’s new cape-less hero.

Research shows that cannabigerol (CBG), a cannabinoid that does not alter brain function, has the ability to resolve infection by methicillin-resistant Staphylococcus aureus, or MRSA. The action of cannabichromene (CBC), cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabinol (THC), as well as other precannabinoids and synthetic molecules, have also been evaluated against the microorganism and its ability to form bacterial biofilms.

These structures, composed of several microbial colonies arranged in a highly ordered fashion, coat living or inert surfaces and contribute to both the virulence and persistence of MRSA. Cannabinoids are compounds of cannabis, which have different functions and interact with the CB1 and CB2 receptors of the endocannabinoid system (ECS). Among other advantages, they are able to destroy malignant bacteria in a different way than man-made antibiotics.

The reason why they help fight antibiotic resistance is because cannabinoids also have their own tricks to attack “superbugs.” That is why, many times, conventional antibiotic treatments are not as effective as cannabis could be.